Journal
GENE THERAPY
Volume 7, Issue 1, Pages 43-52Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.gt.3301054
Keywords
rhesus monkey; CD34 cell; gene transfer; herpes simplex virus; herpes simplex virus thymidine kinase; anti-angiogenesis
Categories
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI094012] Funding Source: NIH RePORTER
- NIAID NIH HHS [AI94012] Funding Source: Medline
Ask authors/readers for more resources
To develop a cellular vehicle able to reach systemically disseminated areas of angiogenesis, we sought to exploit the natural tropism of circulating endothelial progenitor cells (EPCs). Primate CD34(+) EPCs were genetically modified with high efficiency and minimal toxicity using a non-replicative herpes virus vector These EPCs localized in a skin autograft model of angiogenesis in rhesus monkeys, and sustained the expression of a reporter gene for several weeks while circulating in the blood. In animals infused with autologous CD34(+) EPCs transduced with a thymidine kinase-encoding herpes virus, skin autografts and subcutaneous Matrigel pel lets impregnated with vascular growth factors underwent necrosis or accelerated regression after administration of ganciclovir. Importantly, the whole intervention was perfectly well tolerated. The accessibility, easy manipulation, lack of immunogenicity of the autologous CD34+ cell vehicles, and tropism for areas of angiogenesis render autologous CD34+ circulating endothelial progenitors as ideal candidates for exploration of their use as cellular vehicles when systemic gene delivery to those areas is required.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available